Skip to main content
Erschienen in: European Journal of Orthopaedic Surgery & Traumatology 4/2017

06.03.2017 | General Review • HIP - ARTHROPLASTY

Silver-coated megaprostheses: review of the literature

verfasst von: Tom Schmidt-Braekling, Arne Streitbuerger, Georg Gosheger, Friedrich Boettner, Markus Nottrott, Helmut Ahrens, Ralf Dieckmann, Wiebke Guder, Dimosthenis Andreou, Gregor Hauschild, Burkhard Moellenbeck, Wenzel Waldstein, Jendrik Hardes

Erschienen in: European Journal of Orthopaedic Surgery & Traumatology | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Periprosthetic infection remains one of the most serious complications following megaendoprostheses. Despite a large number of preventive measures that have been introduced in recent years, it has not been possible to further reduce the rate of periprosthetic infection. With regard to metallic modification of implants, silver in particular has been regarded as highly promising, since silver particles combine a high degree of antimicrobial activity with a low level of human toxicity. This review provides an overview of the history of the use of silver as an antimicrobial agent, its mechanism of action, and its clinical application in the field of megaendoprosthetics. The benefits of silver-coated prostheses could not be confirmed until now. However, a large number of retrospective studies suggest that the rate of periprosthetic infections could be reduced by using silver-coated megaprostheses.
Literatur
1.
Zurück zum Zitat Gosheger G, Gebert C, Ahrens H, Streitbuerger A, Winkelmann W, Hardes J (2006) Endoprosthetic reconstruction in 250 patients with sarcoma. Clin Orthop Relat Res 450:164–167CrossRefPubMed Gosheger G, Gebert C, Ahrens H, Streitbuerger A, Winkelmann W, Hardes J (2006) Endoprosthetic reconstruction in 250 patients with sarcoma. Clin Orthop Relat Res 450:164–167CrossRefPubMed
2.
Zurück zum Zitat Hardes J, Gebert C, Schwappach A et al (2006) Characteristics and outcome of infections associated with tumor endoprostheses. Arch Orthop Trauma Surg 126(5):289–296CrossRefPubMed Hardes J, Gebert C, Schwappach A et al (2006) Characteristics and outcome of infections associated with tumor endoprostheses. Arch Orthop Trauma Surg 126(5):289–296CrossRefPubMed
3.
Zurück zum Zitat Jeys LM, Luscombe JS, Grimer RJ, Abudu A, Tillman RM, Carter SR (2007) The risks and benefits of radiotherapy with massive endoprosthetic replacement. J Bone Joint Surg (British) 89(10):1352–1355CrossRef Jeys LM, Luscombe JS, Grimer RJ, Abudu A, Tillman RM, Carter SR (2007) The risks and benefits of radiotherapy with massive endoprosthetic replacement. J Bone Joint Surg (British) 89(10):1352–1355CrossRef
4.
Zurück zum Zitat Jeys LM, Grimer RJ, Carter SR, Tillman RM (2005) Periprosthetic infection in patients treated for an orthopaedic oncological condition. J Bone Joint Surg (American) 87(4):842–849 Jeys LM, Grimer RJ, Carter SR, Tillman RM (2005) Periprosthetic infection in patients treated for an orthopaedic oncological condition. J Bone Joint Surg (American) 87(4):842–849
5.
Zurück zum Zitat Kumar D, Grimer RJ, Abudu A, Carter SR, Tillman RM (2003) Endoprosthetic replacement of the proximal humerus. long-term results. J Bone Joint Surg (British) 85(5):717–722 Kumar D, Grimer RJ, Abudu A, Carter SR, Tillman RM (2003) Endoprosthetic replacement of the proximal humerus. long-term results. J Bone Joint Surg (British) 85(5):717–722
6.
Zurück zum Zitat Funovics PT, Hipfl C, Hofstaetter JG, Puchner S, Kotz RI, Dominkus M (2011) Management of septic complications following modular endoprosthetic reconstruction of the proximal femur. Int Orthop 35(10):1437–1444CrossRefPubMed Funovics PT, Hipfl C, Hofstaetter JG, Puchner S, Kotz RI, Dominkus M (2011) Management of septic complications following modular endoprosthetic reconstruction of the proximal femur. Int Orthop 35(10):1437–1444CrossRefPubMed
7.
Zurück zum Zitat Grimer RJ, Carter SR, Tillman RM et al (1999) Endoprosthetic replacement of the proximal tibia. J Bone Joint Surg (British) 81(3):488–494CrossRef Grimer RJ, Carter SR, Tillman RM et al (1999) Endoprosthetic replacement of the proximal tibia. J Bone Joint Surg (British) 81(3):488–494CrossRef
8.
Zurück zum Zitat Racano A, Pazionis T, Farrokhyar F, Deheshi B, Ghert M (2013) High infection rate outcomes in long-bone tumor surgery with endoprosthetic reconstruction in adults: a systematic review. Clin Orthop Relat Res 471(6):2017–2027CrossRefPubMedPubMedCentral Racano A, Pazionis T, Farrokhyar F, Deheshi B, Ghert M (2013) High infection rate outcomes in long-bone tumor surgery with endoprosthetic reconstruction in adults: a systematic review. Clin Orthop Relat Res 471(6):2017–2027CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Hardes J, von Eiff C, Streitbuerger A et al (2010) Reduction of periprosthetic infection with silver-coated megaprostheses in patients with bone sarcoma. J Surg Oncol 101(5):389–395PubMed Hardes J, von Eiff C, Streitbuerger A et al (2010) Reduction of periprosthetic infection with silver-coated megaprostheses in patients with bone sarcoma. J Surg Oncol 101(5):389–395PubMed
10.
Zurück zum Zitat Veerachamy S, Yarlagadda T, Manivasagam G, Yarlagadda PK (2014) Bacterial adherence and biofilm formation on medical implants: a review. Proc Inst Mech Eng Part H J Eng Med 228(10):1083–1099CrossRef Veerachamy S, Yarlagadda T, Manivasagam G, Yarlagadda PK (2014) Bacterial adherence and biofilm formation on medical implants: a review. Proc Inst Mech Eng Part H J Eng Med 228(10):1083–1099CrossRef
11.
12.
Zurück zum Zitat Arciola CR, Campoccia D, An YH et al (2006) Prevalence and antibiotic resistance of 15 minor staphylococcal species colonizing orthopedic implants. Int J Artif Organs 29(4):395–401PubMed Arciola CR, Campoccia D, An YH et al (2006) Prevalence and antibiotic resistance of 15 minor staphylococcal species colonizing orthopedic implants. Int J Artif Organs 29(4):395–401PubMed
13.
Zurück zum Zitat Darouiche RO (2004) Treatment of infections associated with surgical implants. N Engl J Med 350(14):1422–1429CrossRefPubMed Darouiche RO (2004) Treatment of infections associated with surgical implants. N Engl J Med 350(14):1422–1429CrossRefPubMed
14.
Zurück zum Zitat DeJong ES, DeBerardino TM, Brooks DE et al (2001) Antimicrobial efficacy of external fixator pins coated with a lipid stabilized hydroxyapatite/chlorhexidine complex to prevent pin tract infection in a goat model. J Trauma 50(6):1008–1014CrossRefPubMed DeJong ES, DeBerardino TM, Brooks DE et al (2001) Antimicrobial efficacy of external fixator pins coated with a lipid stabilized hydroxyapatite/chlorhexidine complex to prevent pin tract infection in a goat model. J Trauma 50(6):1008–1014CrossRefPubMed
15.
Zurück zum Zitat Ho KM, Litton E Use of chlorhexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection: a meta-analysis J Antimicrob Chemother 58(2) pp. 281–287 (2006). Erratum in J Antimicrob Chemother 65(4) pp. 815 (2010) Ho KM, Litton E Use of chlorhexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection: a meta-analysis J Antimicrob Chemother 58(2) pp. 281–287 (2006). Erratum in J Antimicrob Chemother 65(4) pp. 815 (2010)
16.
Zurück zum Zitat Gosheger G, Hardes J, Ahrens H et al (2004) Silver-coated megaendoprostheses in a rabbit model—an analysis of the infection rate and toxicological side effects. Biomaterials 25(24):5547–5556CrossRefPubMed Gosheger G, Hardes J, Ahrens H et al (2004) Silver-coated megaendoprostheses in a rabbit model—an analysis of the infection rate and toxicological side effects. Biomaterials 25(24):5547–5556CrossRefPubMed
17.
Zurück zum Zitat Alexander JW (2009) History of the medical use of silver. Surg Infect 10(3):289–292CrossRef Alexander JW (2009) History of the medical use of silver. Surg Infect 10(3):289–292CrossRef
18.
Zurück zum Zitat Koller J (2004) Topical treatment of partial thickness burns by silver sulfadiazine plus hyaluronic acid compared to silver sulfadiazine alone: a double-blind, clinical study. Drugs Exp Clin Res 30(5–6):183–190PubMed Koller J (2004) Topical treatment of partial thickness burns by silver sulfadiazine plus hyaluronic acid compared to silver sulfadiazine alone: a double-blind, clinical study. Drugs Exp Clin Res 30(5–6):183–190PubMed
19.
Zurück zum Zitat Brutel de la Riviere A, Dossche KM, Birnbaum DE, Hacker R (2000) First clinical experience with a mechanical valve with silver coating. J Heart Valve Dis 9(1):123–130PubMed Brutel de la Riviere A, Dossche KM, Birnbaum DE, Hacker R (2000) First clinical experience with a mechanical valve with silver coating. J Heart Valve Dis 9(1):123–130PubMed
20.
Zurück zum Zitat Politano AD, Campbell KT, Rosenberger LH, Sawyer RG (2013) Use of silver in the prevention and treatment of infections: silver review. Surg Infect 14(1):8–20CrossRef Politano AD, Campbell KT, Rosenberger LH, Sawyer RG (2013) Use of silver in the prevention and treatment of infections: silver review. Surg Infect 14(1):8–20CrossRef
22.
Zurück zum Zitat Gupta A, Phung LT, Taylor DE, Silver S (2001) Diversity of silver resistance genes in IncH incompatibility group plasmids. Microbiology 147(12):3393–3402CrossRefPubMed Gupta A, Phung LT, Taylor DE, Silver S (2001) Diversity of silver resistance genes in IncH incompatibility group plasmids. Microbiology 147(12):3393–3402CrossRefPubMed
23.
Zurück zum Zitat Alt V, Bechert T, Steinrücke P et al (2004) Nanoparticulate silver. A new antimicrobial substance for bone cement. Orthopade 33(8):885–892CrossRefPubMed Alt V, Bechert T, Steinrücke P et al (2004) Nanoparticulate silver. A new antimicrobial substance for bone cement. Orthopade 33(8):885–892CrossRefPubMed
24.
Zurück zum Zitat Tweden KS, Cameron JD, Razzouk AJ, Holmberg WR, Kelly SJ (1997) Biocompatibility of silver-modified polyester for antimicrobial protection of prosthetic valves. J Heart Valve Dis 6(5):553–561PubMed Tweden KS, Cameron JD, Razzouk AJ, Holmberg WR, Kelly SJ (1997) Biocompatibility of silver-modified polyester for antimicrobial protection of prosthetic valves. J Heart Valve Dis 6(5):553–561PubMed
25.
Zurück zum Zitat Wan AT, Conyers RA, Coombs CJ, Masterton JP (1991) Determination of silver in blood, urine, and tissues of volunteers and burn patients. Clin Chem 37(10):1683–1687PubMed Wan AT, Conyers RA, Coombs CJ, Masterton JP (1991) Determination of silver in blood, urine, and tissues of volunteers and burn patients. Clin Chem 37(10):1683–1687PubMed
26.
Zurück zum Zitat Rosenman KD, Moss A, Kon S (1979) Argyria: clinical implications of exposure to silver nitrate and silver oxide. J Occup Med 21(6):430–435PubMed Rosenman KD, Moss A, Kon S (1979) Argyria: clinical implications of exposure to silver nitrate and silver oxide. J Occup Med 21(6):430–435PubMed
27.
Zurück zum Zitat Hardes J, Ahrens H, Gebert C et al (2007) Lack of toxicological side-effects in silver-coated megaprostheses in humans. Biomaterials 28(18):2869–2875CrossRefPubMed Hardes J, Ahrens H, Gebert C et al (2007) Lack of toxicological side-effects in silver-coated megaprostheses in humans. Biomaterials 28(18):2869–2875CrossRefPubMed
28.
Zurück zum Zitat Glehr M, Leithner A, Friesenbichler J et al (2013) Argyria following the use of silver-coated megaprostheses: no association between the development of local argyria and elevated silver levels. Bone Joint J 95(7):988–992CrossRefPubMed Glehr M, Leithner A, Friesenbichler J et al (2013) Argyria following the use of silver-coated megaprostheses: no association between the development of local argyria and elevated silver levels. Bone Joint J 95(7):988–992CrossRefPubMed
29.
Zurück zum Zitat Scoccianti G, Frenos F, Beltrami G, Campanacci DA, Capanna R (2016) Levels of silver ions in body fluids and clinical results in silver-coated megaprostheses after tumour, trauma or failed arthroplasty. Injury 47(Supplement 4):S11–S16CrossRefPubMed Scoccianti G, Frenos F, Beltrami G, Campanacci DA, Capanna R (2016) Levels of silver ions in body fluids and clinical results in silver-coated megaprostheses after tumour, trauma or failed arthroplasty. Injury 47(Supplement 4):S11–S16CrossRefPubMed
30.
Zurück zum Zitat Donati F, Di Giacomo G, D’Adamio S et al (2016) Silver-coated hip megaprosthesis in oncological limb savage [sic] surgery. Biomed Res Int 2016:6 (Article ID 9079041) CrossRef Donati F, Di Giacomo G, D’Adamio S et al (2016) Silver-coated hip megaprosthesis in oncological limb savage [sic] surgery. Biomed Res Int 2016:6 (Article ID 9079041) CrossRef
31.
Zurück zum Zitat Wafa H, Grimer RJ, Reddy K et al (2015) Retrospective evaluation of the incidence of early periprosthetic infection with silver-treated endoprostheses in high-risk patients: case-control study. Bone Joint J 97(2):252–257CrossRefPubMed Wafa H, Grimer RJ, Reddy K et al (2015) Retrospective evaluation of the incidence of early periprosthetic infection with silver-treated endoprostheses in high-risk patients: case-control study. Bone Joint J 97(2):252–257CrossRefPubMed
32.
Zurück zum Zitat Wilding CP, Cooper GA, Freeman AK, Parry MC, Jeys L (2016) Can a silver-coated arthrodesis implant provide a viable alternative to above knee amputation in the unsalvageable, infected total knee arthroplasty? J Arthroplast 31(11):2542–2547CrossRef Wilding CP, Cooper GA, Freeman AK, Parry MC, Jeys L (2016) Can a silver-coated arthrodesis implant provide a viable alternative to above knee amputation in the unsalvageable, infected total knee arthroplasty? J Arthroplast 31(11):2542–2547CrossRef
33.
Zurück zum Zitat Hardes J, Streitburger A, Ahrens H et al (2007) The influence of elementary silver versus titanium on osteoblasts behaviour in vitro using human osteosarcoma cell lines. Sarcoma 2007:5 (Article ID 26539) CrossRef Hardes J, Streitburger A, Ahrens H et al (2007) The influence of elementary silver versus titanium on osteoblasts behaviour in vitro using human osteosarcoma cell lines. Sarcoma 2007:5 (Article ID 26539) CrossRef
34.
Zurück zum Zitat Hauschild G, Hardes J, Gosheger G et al (2015) Evaluation of osseous integration of PVD-silver-coated hip prostheses in a canine model. Biomed Res Int 2015:10 (Article ID 292406) CrossRef Hauschild G, Hardes J, Gosheger G et al (2015) Evaluation of osseous integration of PVD-silver-coated hip prostheses in a canine model. Biomed Res Int 2015:10 (Article ID 292406) CrossRef
35.
Zurück zum Zitat Schierholz JM, Lucas LJ, Rump A, Pulverer G (1998) Efficacy of silver-coated medical devices. J Hosp Infect 40(4):257–262CrossRefPubMed Schierholz JM, Lucas LJ, Rump A, Pulverer G (1998) Efficacy of silver-coated medical devices. J Hosp Infect 40(4):257–262CrossRefPubMed
36.
Zurück zum Zitat Randall CP, Gupta A, Jackson N, Busse D, O’Neill AJ (2015) Silver resistance in Gram-negative bacteria: a dissection of endogenous and exogenous mechanisms. J Antimicrob Chemother 70(4):1037–1046PubMedPubMedCentral Randall CP, Gupta A, Jackson N, Busse D, O’Neill AJ (2015) Silver resistance in Gram-negative bacteria: a dissection of endogenous and exogenous mechanisms. J Antimicrob Chemother 70(4):1037–1046PubMedPubMedCentral
Metadaten
Titel
Silver-coated megaprostheses: review of the literature
verfasst von
Tom Schmidt-Braekling
Arne Streitbuerger
Georg Gosheger
Friedrich Boettner
Markus Nottrott
Helmut Ahrens
Ralf Dieckmann
Wiebke Guder
Dimosthenis Andreou
Gregor Hauschild
Burkhard Moellenbeck
Wenzel Waldstein
Jendrik Hardes
Publikationsdatum
06.03.2017
Verlag
Springer Paris
Erschienen in
European Journal of Orthopaedic Surgery & Traumatology / Ausgabe 4/2017
Print ISSN: 1633-8065
Elektronische ISSN: 1432-1068
DOI
https://doi.org/10.1007/s00590-017-1933-9

Weitere Artikel der Ausgabe 4/2017

European Journal of Orthopaedic Surgery & Traumatology 4/2017 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.